New Enterprise Associates related stories
All articles and analysis
- Maisonette grabs over $2.7 mln seed
Maisonette, a children's clothing and lifestyle e-commerce site, has raised $2.775 million in seed funding. The investors included New Enterprise Associates and Thrive Partners.

- SetPoint Medical grabs funding from NEA
New Enterprise Associates has made an undisclosed investment in Santa Clarita, California-based SetPoint Medical, a developer of bioelectronic therapy for chronic inflammatory diseases. In conjunction with the funding, Dr. Josh Makower, a general partner at NEA, has been added to SetPoint Medical's board of directors.
- Moximed racks up $50 mln Series C
Moximed Inc, a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis, has raised $50 million in Series C funding. The company's investors include Advent Life Sciences, Future Fund, NEA, Morgenthaler Ventures, GBS Venture Partners and Vertex Healthcare. In conjunction with the funding, Dr. Shahzad Malik, a general partner at Advent Life Sciences and Brigitte Smith, a managing director at GBS Venture Partners, have been added to Moximed's board of directors.
- VC-backed MuleSoft raises $221 mln for IPO
San Francisco-based MuleSoft, a platform provider that helps businesses with connectivity, has debuted its IPO after pricing its 13 million shares at $17 per share. The stock began trading on the New York Stock Exchange on March 17, 2017 under the ticker symbol "MULE." Goldman Sachs and J.P. Morgan Securities LLC are serving as the lead underwriters. MuleSoft's backers included Salesforce Ventures, Cisco Investments, New Enterprise Associates, Lightspeed Venture Partners, Meritech Capital Partners, Bay Partners and Hummer Winblad Venture Partners.

- Canopy snags $20 mln Series B
Canopy, a practice management platform for tax professionals, has secured $20 million in Series B financing. Pelion Venture Partners led the round with participation from return backers New Enterprise Associates, EPIC Ventures and Deep Fork Capital.


- Vertiflex nets $40 mln
Vertiflex Inc, a provider of advanced, minimally invasive interventions for spinal stenosis, has closed $40 million in financing. Endeavour Vision and H.I.G. BioHealth Partners led the round with participation from previous backers New Enterprise Associates, Thomas, McNerney & Partners and Alta Partners.